Not applicableStudy completedNCT02017509What this trial is testingImmunoscore in Rectal CancerWho this might be right forCancer of the RectumNeoplasms, RectalRectal Cancer+2 more Providence Health & Services 3
Testing effectiveness (Phase 2)Study completedNCT03241173What this trial is testingA Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic MalignanciesWho this might be right forAdvanced Malignancies Incyte Biosciences International Sàrl 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267What this trial is testingBasket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Who this might be right forBreast CancerCholangiocarcinomaColorectal Cancer+13 more Hoffmann-La Roche 534
Testing effectiveness (Phase 2)Study completedNCT02983045What this trial is testingA Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid TumorsWho this might be right forMelanomaRenal Cell CarcinomaNon Small Cell Lung Cancer+4 more Nektar Therapeutics 557
Testing effectiveness (Phase 2)Looking for participantsNCT05669430What this trial is testingGV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor MalignanciesWho this might be right forSolid Tumor, AdultRefractory CancerEndometrial Carcinoma (EC)+4 more GV20 Therapeutics 365
Not applicableStudy completedNCT00253383What this trial is testingEarly Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer PatientsWho this might be right forCancer Dartmouth-Hitchcock Medical Center 329
Testing effectiveness (Phase 2)Looking for participantsNCT05288205What this trial is testingPhase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C MutationWho this might be right forKRAS P.G12CNon-small Cell Lung CancerColorectal Cancer+1 more Allist Pharmaceuticals, Inc. 240
Early research (Phase 1)Study completedNCT03454451What this trial is testingCPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersWho this might be right forNon-Small Cell Lung CancerRenal Cell CancerColorectal Cancer+10 more Corvus Pharmaceuticals, Inc. 117
Early research (Phase 1)Looking for participantsNCT06026410What this trial is testingKO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsWho this might be right forSolid Tumors With HRAS AlterationsNon Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+4 more Kura Oncology, Inc. 300
Very early researchNot Yet RecruitingNCT06619886What this trial is testingTP53 R248Q TCR-T Cell Therapy for Advanced Solid TumorWho this might be right forSolid Tumor, AdultLung AdenocarcinomaPancreas Cancer+2 more Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 9
Testing effectiveness (Phase 2)Study completedNCT00006366What this trial is testingRadiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the RectumWho this might be right forColorectal Cancer Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Study completedNCT03724851What this trial is testingVactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric CancerWho this might be right forMetastatic Colorectal CancerGastric CancerGastroesophageal Junction Adenocarcinoma MedPacto, Inc. 120
Early research (Phase 1)Ended earlyNCT03621982What this trial is testingStudy of ADCT-301 in Patients With Selected Advanced Solid TumorsWho this might be right forHead and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more ADC Therapeutics S.A. 78
Early research (Phase 1)Looking for participantsNCT07458347What this trial is testingDose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) MutationWho this might be right forKRAS-mutant Non-small Cell Lung Cancer (NSCLC)KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC)KRAS-mutant Colorectal Cancer (CRC)+1 more Kestrel Therapeutics, Inc. 145
Not applicableStudy completedNCT00462501What this trial is testingCombination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal CancerWho this might be right forColorectal Cancer Memorial Sloan Kettering Cancer Center 35
Early research (Phase 1)Study completedNCT01975831What this trial is testingEvaluate MEDI4736 in Combination With TremelimumabWho this might be right forBreast CancerOvarian CancerColorectal Cancer+2 more Ludwig Institute for Cancer Research 104
Early research (Phase 1)Active Not RecruitingNCT04535401What this trial is testingTesting the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and IntestinesWho this might be right forAdvanced Colorectal CarcinomaAdvanced Digestive System CarcinomaAdvanced Gastric Carcinoma+11 more National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT00831181What this trial is testingNeo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal CancerWho this might be right forColorectal Cancer Beth Israel Medical Center 27
Early research (Phase 1)Study completedNCT00006387What this trial is testingVaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal CancerWho this might be right forColorectal CancerPancreatic Cancer Fox Chase Cancer Center 7
Early research (Phase 1)Ended earlyNCT06466187What this trial is testingSGN-MesoC2 in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Adenocarcinoma+4 more Seagen, a wholly owned subsidiary of Pfizer 19